Approval · Notice of Compliance 33929 · 2024
LISINOPRIL: Notice of Compliance 33929
Issued September 4, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33929
- Date
- September 4, 2024
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Update to labelling (to match Licensor)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LISINOPRIL | Not yet assigned | — |
Medicinal ingredients
- LISINOPRIL 5 MG per TAB
- LISINOPRIL 10 MG per TAB
- LISINOPRIL 20 MG per TAB